Equities research analysts expect that Walgreens Boots Alliance Inc (NASDAQ:WBA) will announce sales of $34.00 billion for the current quarter, according to Zacks Investment Research. Five analysts have made estimates for Walgreens Boots Alliance’s earnings. The lowest sales estimate is $32.19 billion and the highest is $35.97 billion. Walgreens Boots Alliance reported sales of $34.59 billion during the same quarter last year, which indicates a negative year over year growth rate of 1.7%. The company is scheduled to report its next earnings report before the market opens on Thursday, July 9th.

On average, analysts expect that Walgreens Boots Alliance will report full-year sales of $138.63 billion for the current year, with estimates ranging from $134.92 billion to $141.49 billion. For the next year, analysts forecast that the firm will report sales of $143.18 billion, with estimates ranging from $140.30 billion to $149.17 billion. Zacks’ sales calculations are a mean average based on a survey of analysts that cover Walgreens Boots Alliance.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Thursday, April 2nd. The pharmacy operator reported $1.52 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.46 by $0.06. Walgreens Boots Alliance had a return on equity of 21.26% and a net margin of 2.52%. The company had revenue of $35.82 billion for the quarter, compared to the consensus estimate of $35.24 billion. During the same period last year, the business posted $1.64 earnings per share. The firm’s revenue was up 3.7% compared to the same quarter last year.

WBA has been the topic of a number of research analyst reports. Royal Bank of Canada dropped their target price on shares of Walgreens Boots Alliance from $57.00 to $48.00 and set a “sector perform” rating on the stock in a report on Friday, April 3rd. SunTrust Banks decreased their price target on shares of Walgreens Boots Alliance from $58.00 to $42.00 and set a “hold” rating on the stock in a research note on Friday, April 3rd. Morgan Stanley decreased their price target on shares of Walgreens Boots Alliance from $49.00 to $45.00 and set an “equal weight” rating on the stock in a research note on Thursday. Credit Suisse Group decreased their price target on shares of Walgreens Boots Alliance from $60.00 to $50.00 and set a “neutral” rating on the stock in a research note on Friday, April 3rd. Finally, Wells Fargo & Co reiterated a “hold” rating on shares of Walgreens Boots Alliance in a research note on Thursday, April 2nd. Three analysts have rated the stock with a sell rating and thirteen have issued a hold rating to the company’s stock. The company presently has a consensus rating of “Hold” and an average price target of $49.23.

Hedge funds have recently made changes to their positions in the business. Norges Bank purchased a new position in Walgreens Boots Alliance during the fourth quarter valued at approximately $492,928,000. Aristotle Capital Management LLC raised its holdings in Walgreens Boots Alliance by 53.2% during the 1st quarter. Aristotle Capital Management LLC now owns 7,289,353 shares of the pharmacy operator’s stock valued at $333,488,000 after buying an additional 2,529,868 shares during the last quarter. APG Asset Management N.V. raised its holdings in Walgreens Boots Alliance by 105.4% during the 1st quarter. APG Asset Management N.V. now owns 4,695,281 shares of the pharmacy operator’s stock valued at $264,568,000 after buying an additional 2,409,392 shares during the last quarter. JPMorgan Chase & Co. increased its stake in shares of Walgreens Boots Alliance by 17.6% in the 1st quarter. JPMorgan Chase & Co. now owns 9,039,778 shares of the pharmacy operator’s stock worth $413,569,000 after acquiring an additional 1,350,716 shares in the last quarter. Finally, Nuveen Asset Management LLC increased its stake in shares of Walgreens Boots Alliance by 57.4% in the 1st quarter. Nuveen Asset Management LLC now owns 3,291,920 shares of the pharmacy operator’s stock worth $150,606,000 after acquiring an additional 1,200,358 shares in the last quarter. 57.23% of the stock is currently owned by institutional investors and hedge funds.

Shares of NASDAQ:WBA traded up $1.16 during trading on Friday, reaching $43.14. The stock had a trading volume of 4,114,717 shares, compared to its average volume of 5,878,421. The company has a debt-to-equity ratio of 1.34, a current ratio of 0.66 and a quick ratio of 0.32. The business’s 50-day moving average price is $42.00 and its 200 day moving average price is $47.69. Walgreens Boots Alliance has a 52 week low of $36.65 and a 52 week high of $64.50. The stock has a market capitalization of $36.83 billion, a PE ratio of 11.13, a P/E/G ratio of 2.50 and a beta of 0.55.

The company also recently declared a quarterly dividend, which was paid on Friday, June 12th. Investors of record on Wednesday, May 20th were issued a dividend of $0.4575 per share. This represents a $1.83 annualized dividend and a yield of 4.24%. The ex-dividend date of this dividend was Tuesday, May 19th. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently 30.55%.

About Walgreens Boots Alliance

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. It operates through three segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment sells prescription drugs and an assortment of retail products, including health, beauty, personal care, consumable, and general merchandise products through its retail drugstores and convenient care clinics.

See Also: volatile stocks

Get a free copy of the Zacks research report on Walgreens Boots Alliance (WBA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance and related companies with MarketBeat.com's FREE daily email newsletter.